The role of metformin in the treatment of type 2 diabetes and obesity's
Topic: Mutual association and connection study between the obesity, visceral obesity, insulin desensitation (with the conesquential hyperinsulinemia), type 2 diabetes, dyslipoproteinemia and anthropometric characteristics of the patients with the metabolic syndrom are the subject of many epidemiolog...
Saved in:
Main Author: | Vuković Mira H. (Author) |
---|---|
Format: | Book |
Published: |
Srpsko lekarsko drustvo,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
by: Shereen M. Aleidi, et al.
Published: (2021) -
Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
by: Sicras-Mainar A, et al.
Published: (2014) -
Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
by: Muhammad Mujammami, et al.
Published: (2023) -
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
by: Michael Ashamalla, et al.
Published: (2018) -
Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
by: Christina S. Kwon, et al.
Published: (2018)